June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
PDT timing dependent regression of corneal blood and lymphatic vessels after intravenous Verteporfin injection
Author Affiliations & Notes
  • Yanhong Hou
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Felix Bock
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Claus Cursiefen
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Footnotes
    Commercial Relationships   Yanhong Hou, None; Felix Bock, None; Claus Cursiefen, None
  • Footnotes
    Support  DFG FOR2240; EU ARREST BLINDNESS
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1002. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yanhong Hou, Felix Bock, Claus Cursiefen; PDT timing dependent regression of corneal blood and lymphatic vessels after intravenous Verteporfin injection. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1002.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pathological corneal (lymph)angiogenesis is a known risk factor for immune-mediated allograft rejection after keratoplasty. However, there is no efficient treatment to regress pre-existing pathological corneal blood and lymphatic vessels in vascularized high-risk eyes prior to corneal transplantation. This study assessed the possibility to regress corneal blood and lymphatic vessels by photodynamic therapy (PDT) after systemic intravenous Verteporfin injection and the influence of timing of PDT after injection of the photosensitizer.

Methods : Female BALB/c mice were used for suture-induced inflammatory corneal neovascularization to induce combined hem- and lymphangiogenesis. Thereafter, the treatment group received PDT treatment 3 minutes, 1 hour and 24 hours after an intravenous injection of Verteporfin (control group: phosphate buffered saline (PBS)). Corneas were excised 3 days after corneal photodynamic therapy and corneal flatmounts were stained with FITC-conjugated CD31 and LYVE-1 to quantify hem- and lymphangiogenesis.

Results : Corneal blood vessels showed a significant reduction when PDT was performed 3 minutes after Verteporfin injection (p<0.05) while lymphatic vessels showed no significant difference. Both blood vessels (BV) and lymphatic vessels (LV) were significantly regressed when performing PDT 1 hour (BV: p<0.01; LV: p<0.001) or 24 hours (BV: p<0.05; LV: p<0.01) after intravenous application of Verteporfin.

Conclusions : This study shows that PDT after intravenous injection of Verteporfin can selectively regress pre-existing corneal blood vessels or both blood and lymphatic vessels depending on the timing of PDT after injection. PDT 1 hour and more after a systemic photosensitizer injection destroys both vessel types.
Therefore, this PDT strategy might be a promising anti(lymph)angiogenic method to reduce pre-existing blood and lymphatic vessels prior to keratoplasty in high-risk eyes to promote corneal graft survival.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×